‘Putting Electric Motors Into Classic Cars’ – Burt Sets Out European Potential Of Value Added Medicines

Pharmanovia CEO James Burt recently took over as chair of Medicines for Europe’s value added medicines sector group. In an exclusive interview with Generics Bulletin, he looks to the future for innovation around known medicines in Europe, including landmark EU legislation on the horizon and the importance of stakeholder dialogue throughout the supply chain.